BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37339157)

  • 1. Cash flow management and its effect on firm performance: Empirical evidence on non-financial firms of China.
    Laghari F; Ahmed F; López García MLN
    PLoS One; 2023; 18(6):e0287135. PubMed ID: 37339157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Country risk, global uncertainty, and firms' cash holdings: Do the role of law, culture, and financial market development matter?
    Athari SA; Cho Teneng R; Çetinkaya B; Bahreini M
    Heliyon; 2024 Mar; 10(5):e26266. PubMed ID: 38463892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 impact on firm investment-Evidence from Chinese publicly listed firms.
    Jiang J; Hou J; Wang C; Liu H
    J Asian Econ; 2021 Aug; 75():101320. PubMed ID: 36567767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the dynamics of capital structure, corporate governance, and corporate social responsibility in high- and low-leveraged US and Chinese firms.
    Mahmood AN; Arslan HM; Younas ZI; Komal B; Ali K; Mubeen M
    Environ Sci Pollut Res Int; 2023 Apr; 30(16):46204-46221. PubMed ID: 36710308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Firms' COVID-19 Pandemic Exposure and Corporate Cash Policy: Evidence from China.
    He Z; Suardi S; Wang K; Zhao Y
    Econ Model; 2022 Nov; 116():105999. PubMed ID: 36032988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do the trade credit influence firm performance in agro-industry? Evidence from Thailand.
    Detthamrong U; Chansanam W
    Heliyon; 2023 Mar; 9(3):e14561. PubMed ID: 36950577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do public subsidies trigger firms' overinvestment? Evidence from the Korean renewable energy technology industry.
    Sung B; Park SD; Choi MS
    Environ Sci Pollut Res Int; 2023 Jan; 30(2):3367-3382. PubMed ID: 35948791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAMILY FIRMS, BANK RELATIONSHIPS, AND FINANCIAL CONSTRAINTS: A COMPREHENSIVE SCORE CARD.
    Karaivanov A; Saurina J; Townsend RM
    Int Econ Rev (Philadelphia); 2019 May; 60(2):547-593. PubMed ID: 31333276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of COVID-19 on the valuations of non-financial European firms.
    Abbas Rizvi SK; Yarovaya L; Mirza N; Naqvi B
    Heliyon; 2022 Jun; 8(6):e09486. PubMed ID: 35634174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it good to hold more cash before the pandemic? A case of Taiwanese firms.
    Wu SW; Nguyen MT; Mai NT; Tsai JF
    Heliyon; 2023 Jun; 9(6):e16050. PubMed ID: 37260906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous cash dividends, ownership structure and firm value: Evidence from Chinese A-share market.
    Qi Q; Li W; Liu C; Huang Y; Hu C
    PLoS One; 2022; 17(3):e0265177. PubMed ID: 35298495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does corporate environmental investment impede financial performance of Chinese enterprises? The moderating role of financial constraints.
    Akbar A; Jiang X; Qureshi MA; Akbar M
    Environ Sci Pollut Res Int; 2021 Nov; 28(41):58007-58017. PubMed ID: 34101121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into corporate sustainability, environmental management and corporate financial performance in European Union: an application of VAR and Granger causality approach.
    Ivascu L; Domil A; Sarfraz M; Bogdan O; Burca V; Pavel C
    Environ Sci Pollut Res Int; 2022 Nov; 29(55):82827-82843. PubMed ID: 35754081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unveiling the Effectiveness of Agency Cost and Firms' Size as Moderators Between CSR Disclosure and Firms' Growth.
    Akram A; Tang Y; Tariq J
    Front Psychol; 2020; 11():1624. PubMed ID: 32903572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Executive compensation controls and corporate cash holdings.
    Wang P; Zhang X; Wang T; Wan Z
    PLoS One; 2023; 18(9):e0285387. PubMed ID: 37682923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Working capital management, financial constraints and exports: evidence from European and US manufacturers.
    Mansilla-Fernández JM; Milgram-Baleix J
    Empir Econ; 2023; 64(4):1769-1810. PubMed ID: 36034740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financial performance of China's listed firms in presence of coronavirus: Evidence from corporate culture and corporate social responsibility.
    Zheng F; Zhao Z; Sun Y; Khan YA
    Curr Psychol; 2023; 42(11):8897-8918. PubMed ID: 34400856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of flooding on firm performance and economic growth.
    Pan X; Qiu B
    PLoS One; 2022; 17(7):e0271309. PubMed ID: 35830442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adopting Occupational Health and Safety Management Standards: The Impact on Financial Performance in Pharmaceutical Firms in China.
    Yang M; Maresova P
    Risk Manag Healthc Policy; 2020; 13():1477-1487. PubMed ID: 32982506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of corporate digital transformation on firms' performance in utilities sector.
    Wang D; Xia X
    Heliyon; 2024 Jan; 10(1):e23362. PubMed ID: 38169836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.